ATYR FY 2023 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$93M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$353,000-96.6% YoY

Gross Profit

$353,000100.0% margin

Operating Income

-$55M-15557.8% margin

Net Income

-$50M-14274.5% margin

EPS (Diluted)

$-0.94

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$37M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$121M

Total Liabilities

$30M

Stockholders' Equity

$91M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$353,000	$10M	-96.6%
Gross Profit	$353,000	$9M	-95.9%
Operating Income	-$55M	-$46M	-18.3%
Net Income	-$50M	-$45M	-11.1%